R-Pharm Of Russia To Establish Turkey Unit For Mideast, Africa Sales
This article was originally published in PharmAsia News
Executive Summary
Russia's R-Pharm said it set up a Turkey subsidiary for $130.5 million to produce its biotechnology products for export to Middle East and Africa markets.